Keeping Track: Enhertu Brings Anti-HER2 Therapy To Lung Cancer; Novaliq Platform Supports Two Dry Eye NDAs

 
• By Bridget Silverman
Keeping Track Feature image
• Source: Pink Sheet Illustration

More from US FDA Performance Tracker

More from Regulatory Trackers